Filter posts

FDA’s Historic Gene Therapy Approvals Could Be Beginning of the End of Blood Cancer

In his inaugural address this June as chairman of the world’s largest biotechnology industry group, …

Alnylam CEO John Maraganore Takes the Reins as BIO Chair

John Maraganore, CEO of Cambridge-based Alnylam Pharmaceuticals, begins his chairmanship of BIO this morning when …